Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany.
Heike BorthAnna TeubertRalf GlaubitzSarah KnippenbergNargül KuturThomas WinklerBernd EibenPublished in: Archives of gynecology and obstetrics (2020)
The VeriSeq NIPT Solution v2 assay detected fetal chromosomal aneuploidies across a range of fetal fractions with high sensitivities and specificities observed based on known clinical outcomes, a high overall PPV, and a low failure rate.
Keyphrases